TA
TFG Advisers’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,405
| Closed | -$242K | – | 210 |
|
|
2024
Q3 | $242K | Hold |
1,405
| – | – | 0.09% | 191 |
|
|
2024
Q2 | $216K | Sell |
1,405
-733
| -34% | -$113K | 0.08% | 188 |
|
|
2024
Q1 | $329K | Sell |
2,138
-80
| -4% | -$12.3K | 0.13% | 152 |
|
|
2023
Q4 | $351K | Sell |
2,218
-304
| -12% | -$48.1K | 0.15% | 143 |
|
|
2023
Q3 | $369K | Sell |
2,522
-468
| -16% | -$68.5K | 0.17% | 133 |
|
|
2023
Q2 | $458K | Sell |
2,990
-95
| -3% | -$14.5K | 0.21% | 118 |
|
|
2023
Q1 | $478K | Sell |
3,085
-30
| -1% | -$4.65K | 0.23% | 108 |
|
|
2022
Q4 | $480K | Sell |
3,115
-242
| -7% | -$37.3K | 0.25% | 107 |
|
|
2022
Q3 | $443K | Sell |
3,357
-216
| -6% | -$28.5K | 0.25% | 101 |
|
|
2022
Q2 | $484K | Sell |
3,573
-200
| -5% | -$27.1K | 0.26% | 102 |
|
|
2022
Q1 | $563K | Sell |
3,773
-63
| -2% | -$9.4K | 0.26% | 103 |
|
|
2021
Q4 | $621K | Sell |
3,836
-220
| -5% | -$35.6K | 0.27% | 100 |
|
|
2021
Q3 | $674K | Sell |
4,056
-16
| -0.4% | -$2.66K | 0.33% | 88 |
|
|
2021
Q2 | $703K | Sell |
4,072
-21
| -0.5% | -$3.63K | 0.34% | 85 |
|
|
2021
Q1 | $657K | Sell |
4,093
-321
| -7% | -$51.5K | 0.34% | 83 |
|
|
2020
Q4 | $741K | Buy |
4,414
+37
| +0.8% | +$6.21K | 0.39% | 76 |
|
|
2020
Q3 | $688K | Hold |
4,377
| – | – | 0.4% | 74 |
|
|
2020
Q2 | $734K | Sell |
4,377
-17
| -0.4% | -$2.85K | 0.48% | 67 |
|
|
2020
Q1 | $576K | Sell |
4,394
-2
| -0% | -$262 | 0.46% | 70 |
|
|
2019
Q4 | $653K | Sell |
4,396
-472
| -10% | -$70.1K | 0.37% | 77 |
|
|
2019
Q3 | $602K | Sell |
4,868
-141
| -3% | -$17.4K | 0.4% | 79 |
|
|
2019
Q2 | $705K | Sell |
5,009
-188
| -4% | -$26.5K | 0.48% | 73 |
|
|
2019
Q1 | $784K | Sell |
5,197
-4
| -0.1% | -$603 | 0.57% | 66 |
|
|
2018
Q4 | $646K | Buy |
+5,201
| New | +$646K | 0.54% | 66 |
|